Why Employers Think the 340B Program Needs Reform
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows…
Why Employers Think the 340B Program Needs Reform
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to “buy low and sell high” by purchasing discounted medications and charging insured patients full price. The post Why Employers Think the 340B Program Needs Reform appeared first on MedCity News.
BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal
Neopharmed Gentili is acquiring European rights to Orladeyo, bringing the Italy-based pharmaceutical company into rare disease. BioCryst’s Orladeyo is approved for treating patients with the rare disease hereditary angioedema. The post BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal appeared first on MedCity News.
No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net
Through the convergence of proactive policy, advanced technology and strategic public-private partnerships, we can achieve this “no wrong door” vision and deliver a connected, streamlined social safety net that’s more efficient, economical, and effective. Here’s how. The post No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net appeared first…
The Administration’s Autism Plan Is Controversial – But It Also Presents a Vital Opportunity
Public debate is growing, but the real path forward lies in defining autism’s biology — and for the first time, we can. The post The Administration’s Autism Plan Is Controversial – But It Also Presents a Vital Opportunity appeared first on MedCity News.
The $232 Billion Problem: The Price of Overlooking the Impact of Trauma in the U.S.
When we talk about post-traumatic stress disorder (PTSD), a condition fundamentally born from overwhelming experiences that leave a long-term imprint on the body, our mainstream approach often feels stuck in the past. The post The $232 Billion Problem: The Price of Overlooking the Impact of Trauma in the U.S. appeared first on MedCity News.
Journalists Break Down Reconciliation Bill, Vaccine Panel Meeting, and ‘Dobbs’ Anniversary
KFF Health News senior correspondent Phil Galewitz discussed Medicaid and Supplemental Nutrition Assistance Program cuts on “CBS Morning News” on June 26. Click here to watch Galewitz on “CBS Morning News” Read Galewitz and Stephanie Armour’s “Too Sick To Work, Some Americans Worry Trump’s Bill Will Strip Their Health Insurance” KFF Health News senior correspondent…
Innovative Strategies to Enhance Financial Predictability for Self-Funded Employers
Too often, the very systems meant to provide flexibility and control are undermined by delayed reimbursements, fragmented data, and a lack of transparency across the ecosystem. Solving this isn’t about tweaking the status quo, it requires a full redesign. The post Innovative Strategies to Enhance Financial Predictability for Self-Funded Employers appeared first on MedCity News.
Weekend Reading
Renaming schizophrenia: why, how, and what next?COVID-19 winners and losers.Labor market (not supply chain) caused COVID-19 inflation?Medicare Advantage dental benefits.NC eliminating parking minimums.
Ballad Health CIO: Tech Should ‘Fade into the Background’
Pam Austin, CIO of Ballad Health, detailed how her health system is helping clinicians spend less time on screens and more time with patients. The post Ballad Health CIO: Tech Should ‘Fade into the Background’ appeared first on MedCity News.
How Healthcare Leaders Are Responding to the Supreme Court’s Preventive Care Ruling
The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded the decision, though some concerns remain. The post How Healthcare Leaders Are Responding to the Supreme Court’s Preventive Care Ruling appeared first on MedCity News.
